Concentrix Corp Files Additional Proxy Materials

TL;DR

CNXC filed more proxy docs, no new fee. Standard shareholder stuff.

AI Summary

Concentrix Corporation filed a Definitive Additional Materials proxy statement on September 24, 2024. This filing is related to the company's proxy materials and does not require a new filing fee. The company is incorporated in Delaware and its fiscal year ends on November 30.

Why It Matters

This filing indicates that Concentrix is providing supplementary information to shareholders regarding proxy matters, which is a standard part of corporate governance and shareholder communication.

Risk Assessment

Risk Level: low — This filing is a routine proxy statement update and does not contain information that suggests significant new risks or changes in the company's risk profile.

Key Players & Entities

• Concentrix Corporation (company) — Registrant
• 0001803599-24-000146 (filing_id) — Accession Number
• 20240924 (date) — Filing Date
• DE (state) — State of Incorporation
• 1130 (fiscal_year_end) — Fiscal Year End

FAQ

Filing Documents

• defa14a-additionalproxymat.htm (DEFA14A) — 29KB
• cnx_fullcolorseptember2024.jpg (GRAPHIC) — 40KB
• 0001803599-24-000146.txt ( ) — 84KB

From the Filing

Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement Definitive Additional Materials Soliciting Material Pursuant to 240.14a-12 Concentrix Corporation (Name of Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check the appropriate box) No fee required. Fee paid previously with preliminary materials. Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. ____________________________________________________________________________________________________ (3) Filing Party ____________________________________________________________________________________________________ (4) Date Filed ____________________________________________________________________________________________________ Supplement to Proxy Statement For the Special Meeting of Stockholders To be held on October 28, 2024 This supplement (the "Supplement") amends and supplements the definitive proxy statement on Schedule 14A (the "Proxy Statement") filed by Concentrix Corporation (the "Company") with the U.S. Securities and Exchange Commission relating to the Company's Special Meeting of Stockholders (the "Special Meeting") to be held on October 28, 2024. After the Company filed its Proxy Statement, one purported stockholder of the Company sent the Company a demand letter asserting that the Proxy Statement's description of the vote required for approval of Proposal Nos. 2 and 3, and the effect of abstentions on the vote, is "confusingly inconsistent." While the Company believes that the alleged inconsistencies in the Proxy Statement are immaterial, to moot this disclosure claim, avoid nuisance and business delays, and provide additional information to its stockholders, the Company has determined to voluntarily amend certain disclosures in the Proxy Statement with the supplemental disclosures set forth below (the "Supplemental Disclosures") under the heading "Supplemental Disclosures to the Proxy Statement." Nothing in the Supplemental Disclosures shall be deemed an admission of the legal merit, necessity or materiality under applicable laws of any of the disclosures set forth herein. To the contrary, the Company specifically denies all allegations that any additional disclosure was or is required or material. Other than the Supplemental Disclosures listed below, the Proxy Statement remains unchanged, and this Supplement does not otherwise amend, supplement, or affect the Proxy Statement. From and after the date of this Supplement, any references to the "Proxy Statement" are to the Proxy Statement as amended and supplemented by this Supplement. This Supplement should be read in conjunction with the Proxy Statement and the other proxy materials previously made available to stockholders in connection with the Special Meeting. If you have already voted your shares, you do not need to vote again unless you would like to change or revoke your prior vote on any proposal. Supplemental Disclosures to the Proxy Statement The text under "About the Special Meeting—How to Vote at the Special Meeting—Beneficial Owners" section of the Proxy Statement is amended and restated in its entirety to read as follows (amendments are marked, with new text bold and underlined, and deleted text bold and stricken through) Beneficial Owners . If you hold your shares of Common Stock in a brokerage account or through a bank or other nominee, your broker, bank, or other nominee is considered the "stockholder of record" and you are considered the "beneficial owner" of the shares. In this case, your broker, bank, or other nominee is responsible for providing you with instructions on how to vote. If you are a beneficial owner and want to vote your shares of Common Stock at the virtual Special Meeting, you will need the unique 16-digit control number that appears on the instructions that accompanied the notice of internet availability or the proxy materials that you received. A broker non-vote occurs when (i) the bank, broker, trust or other nominee has discretionary voting power on routine proposals to be considered at a meeting of stockholders but does not have discretionary voting power on other proposals to be considered at such meeting because they are non-routine and (ii) the bank, broker, trust or other nominee has not received voting instructions from the beneficial owner on a non-routine proposal. A bank, broker, trust or other nominee may exercise discretion in voting on routine matters but may not exercise discretion, and therefore cannot vote, on no

View Full Filing

View this DEFA14A filing on SEC EDGAR